The Complementary Effects of Dabigatran Etexilate and Exercise Training on the Development and Stability of the Atherosclerotic Lesions in Diabetic ApoE Knockout Mice. [PDF]
Pharmaceuticals (Basel), 2023 Kadoglou NP +5 more
europepmc +1 more source
Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism [PDF]
, 2017 Anticoagulation for the long-term treatment and prevention of thrombo-embolic diseases as well as for stroke prevention in atrial fibrillation (AF) has been accomplished by vitamin K antagonists for the last half century. Although effective under optimal
Braunwald, Eugene, Steffel, Jan
core
Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases [PDF]
, 2013 We present the case of an aphasic 77-year-old stroke patient with left distal M1 occlusion who received rt-PA for thrombolysis while on oral anticoagulant treatment with dabigatran (150 mg b.i.d.).
Abruscato, Mario Giovanni Rosario +3 more
core +2 more sources
Dabigatran etexilate: a direct thrombin inhibitor
Italian Journal of Medicine, 2013 BACKGROUND Direct Thrombin Inhibitors (DTIs) represent a new and promising class of anticoagulants. Unlike heparin, they directly interact with thrombin and block fibrinogen binding.
M. Dugnani
doaj +1 more source
Ten Minutes Vestibular Examinations but Persistent Rehabilitative Exercises [PDF]
, 2013 Symposium on Neurology Highlight - S16Vertigo is a common illness that patients seek consultation in ENT clinics. Patients often have a hallucination of environmental rotation while patients with dizziness often have a sense of lightheadedness.
Au, DKK
core
Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation. [PDF]
, 2015 Stroke is a leading cause of morbidity and mortality worldwide. Atrial fibrillation (AF) is an independent risk factor for stroke, increasing the risk five-fold.
Andreotti, F +5 more
core +1 more source
DABIGATRAN ETEXILATE IN ELDERL Y PATIENTS WITH ATRIAL FIBRILLATION: WHATS NEW?
Евразийский Кардиологический Журнал, 2017 The article discusses stroke prevention in elderly patients with atrial fibrillation. The principles of choosing anticoagulant therapy in this group of patients are discussed.
O. N. Tkacheva, N. M. Vorobyeva
doaj +1 more source
Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation. [PDF]
Front Cardiovasc Med, 2022 Liu YO +14 more
europepmc +1 more source
Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study [PDF]
, 2015 BACKGROUND & AIMS: Use of dabigatran, an inhibitor of thrombin, increases the risk of gastrointestinal bleeding (GIB). However, it is not clear whether gastroprotective agents (GPAs) prevent GIB in dabigatran users.
Chan, EW +6 more
core
Extremely elevated international normalized ratio in a patient using dabigatran etexilate: a case report [PDF]
, 2023 Jin Kim +4 more
openalex +1 more source